Last update at 2025-03-14T05:10:00Z
Atlas Arteria's (ASX:ALX) Solid Earnings May Rest On Weak Foundations
Tue 11 Mar 25, 08:37 PMAtlas Arteria Ltd (MAQAF) (FY 2024) Earnings Call Highlights: Strong Revenue Growth and ...
Thu 27 Feb 25, 09:00 AM3 ASX Stocks That May Be Priced Below Their Estimated Intrinsic Value
Thu 30 Jan 25, 08:02 AM3 ASX Stocks Estimated To Be Up To 50.2% Below Intrinsic Value
Tue 31 Dec 24, 08:02 AMASX Stocks That May Be Trading Below Their Estimated Value In November 2024
Mon 18 Nov 24, 08:03 AMASX's Top 3 Estimated Undervalued Stocks For September 2024
Tue 03 Sep 24, 07:08 PMAtlas Arteria Ltd's Dividend Analysis
Mon 25 Mar 24, 11:06 AMAtlas Arteria Full Year 2023 Earnings: EPS: AU$0.22 (vs AU$0.25 in FY 2022)
Thu 29 Feb 24, 08:29 PM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 244.20M | 127.93M | -63.49400M | -19.02600M | 60.75M |
| Minority interest | 25.95M | - | - | - | - |
| Net income | 266.96M | 163.70M | -55.80500M | -9.82100M | 59.85M |
| Selling general administrative | 9.77M | 4.75M | 7.51M | 33.89M | 119.30M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 64.85M | 51.45M | 61.13M | 125.14M | 94.69M |
| Reconciled depreciation | 66.25M | 61.48M | 67.44M | 70.28M | 62.12M |
| Ebit | 335.16M | 259.28M | 167.49M | 258.71M | 169.67M |
| Ebitda | 401.40M | 320.76M | 234.93M | 329.00M | 231.79M |
| Depreciation and amortization | 66.25M | 61.48M | 67.44M | 70.28M | 62.12M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 335.16M | 259.28M | 167.49M | 258.71M | -92.16400M |
| Other operating expenses | 141.59M | 125.43M | 135.25M | 170.36M | 218.97M |
| Interest expense | 90.96M | 131.35M | 87.08M | 112.31M | 108.92M |
| Tax provision | 3.19M | -35.76700M | -7.68900M | -9.20500M | 0.90M |
| Interest income | 22.13M | 0.14M | 196.09M | 254.87M | 246.14M |
| Net interest income | -68.83000M | -131.20600M | -84.99100M | -104.88200M | -104.12200M |
| Extraordinary items | - | - | - | - | 0.00000M |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 3.19M | -35.76700M | -7.68900M | -9.20500M | 0.90M |
| Total revenue | 116.73M | 99.53M | 103.53M | 166.93M | 126.81M |
| Total operating expenses | 89.71M | 77.35M | 92.86M | 128.57M | 186.85M |
| Cost of revenue | 51.88M | 48.08M | 42.39M | 41.78M | 32.13M |
| Total other income expense net | -90.95800M | -131.34600M | -230.98100M | -277.74000M | 152.91M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 241.01M | 163.70M | -55.80500M | -9.82100M | 59.85M |
| Net income applicable to common shares | 241.01M | 163.70M | -55.80500M | -9.82100M | 59.85M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Total assets | 8262.00M | 8044.70M | 8318.53M | 5219.18M | 5219.04M |
| Intangible assets | 2215.40M | 2103.50M | 2167.91M | 2101.41M | 2064.34M |
| Earning assets | - | - | - | - | - |
| Other current assets | 3.00M | - | 4.31M | 2.77M | 267.64M |
| Total liab | 1949.80M | 1809.10M | 1828.06M | 1721.19M | 1634.59M |
| Total stockholder equity | 3340.80M | 3370.40M | 6490.47M | 3497.99M | 3584.45M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 21.70M | 17.10M | 23.33M | 16.21M | 17.56M |
| Common stock | 3994.00M | - | 6985.03M | 3949.82M | 3949.82M |
| Capital stock | 3994.00M | 3994.00M | 6985.03M | 3949.82M | 3949.82M |
| Retained earnings | -903.50000M | -731.50000M | -586.53400M | -439.14300M | -373.60100M |
| Other liab | - | - | - | - | - |
| Good will | 14.70M | 14.30M | 13.82M | 13.72M | 14.09M |
| Other assets | - | - | 237.51M | 250.12M | 224.22M |
| Cash | 351.50M | 305.30M | 275.90M | 229.39M | 260.34M |
| Cash and equivalents | - | - | 275.90M | 229.39M | 260.34M |
| Total current liabilities | 134.30M | 118.80M | 123.76M | 108.96M | 72.03M |
| Current deferred revenue | - | - | - | - | - |
| Net debt | 1496.70M | 1389.70M | 1459.43M | 1419.90M | 1285.01M |
| Short term debt | 112.60M | - | 100.43M | 92.75M | 54.47M |
| Short long term debt | 112.40M | 101.40M | 100.11M | 92.30M | 53.21M |
| Short long term debt total | 1848.20M | - | 1735.33M | 1649.29M | 1545.35M |
| Other stockholder equity | - | - | 2.63M | -44.04300M | 8.23M |
| Property plant equipment | - | - | 15.68M | 16.92M | 13.27M |
| Total current assets | 366.50M | 345.10M | 533.51M | 245.19M | 267.64M |
| Long term investments | 5416.40M | 5341.60M | 5350.11M | 2591.82M | 2635.47M |
| Net tangible assets | - | - | - | - | - |
| Short term investments | - | - | 245.77M | - | - |
| Net receivables | 12.00M | 5.30M | 7.53M | 13.02M | 5.68M |
| Long term debt | 1708.40M | 1593.60M | 1609.45M | 1532.06M | 1470.96M |
| Inventory | - | - | - | - | -266.02400M |
| Accounts payable | - | - | - | - | - |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 250.30M | - | 91.98M | -12.68800M | 8.23M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | 3949.82M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 215.80M | 205.00M | 215.63M | 226.59M | 224.22M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 7895.50M | 7699.60M | 7785.02M | 4974.00M | 4951.39M |
| Capital lease obligations | 27.40M | 25.50M | 25.77M | 24.93M | 21.18M |
| Long term debt total | - | - | 1634.90M | 1556.55M | 1490.88M |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Investments | 633.00M | 631.70M | -2605.56500M | 304.05M | -976.67300M |
| Change to liabilities | - | - | - | - | - |
| Total cashflows from investing activities | - | - | -2605.56500M | 304.05M | -976.67300M |
| Net borrowings | - | - | - | - | - |
| Total cash from financing activities | -683.80000M | -673.00000M | 2573.35M | -381.80100M | -246.62100M |
| Change to operating activities | - | - | - | - | - |
| Net income | 335.90M | 323.50M | 266.96M | 163.70M | -55.80500M |
| Change in cash | 46.20M | 29.40M | 46.51M | -30.95200M | -1189.88000M |
| Begin period cash flow | 305.30M | 275.90M | 229.39M | 260.34M | 1450.22M |
| End period cash flow | 351.50M | 305.30M | 275.90M | 229.39M | 260.34M |
| Total cash from operating activities | - | 84.70M | 333.20M | 47.12M | 39.33M |
| Issuance of capital stock | - | - | 3043.38M | - | 483.94M |
| Depreciation | - | 69.20M | 66.25M | 61.48M | 67.44M |
| Other cashflows from investing activities | 634.10M | 637.80M | -2605.20800M | 305.72M | -966.13100M |
| Dividends paid | 580.40M | 580.40M | 388.40M | 273.32M | 105.49M |
| Change to inventory | - | - | - | - | - |
| Change to account receivables | - | 2.00M | -3.35000M | -0.69800M | 0.17M |
| Sale purchase of stock | - | -0.20000M | -7.84600M | 0.00000M | 483.94M |
| Other cashflows from financing activities | -3.60000M | 9.00M | 21.47M | 184.40M | 7.68M |
| Change to netincome | - | - | - | - | - |
| Capital expenditures | 1.10M | 0.80M | 0.36M | 1.47M | 1.44M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | - | 6.40M | 17.95M | 0.97M | -7.13200M |
| Stock based compensation | - | 0.70M | 0.62M | 2.42M | 2.15M |
| Other non cash items | - | -315.10000M | -333.20400M | -225.17700M | -11.63400M |
| Free cash flow | 92.10M | 712.80M | 332.85M | 45.65M | 37.89M |
Sector: Industrials Industry: Infrastructure Operations
| Company | Change (AUD) | Price (AUD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ALX Atlas Arteria |
- -% | 4.99 | 21.57 | 26.81 | 49.32 | 2.13 | 59.35 | 19.39 |
| TCL Transurban Group |
- -% | 12.75 | 421.50 | 112.36 | 10.27 | 3.82 | 15.16 | 26.32 |
| VNT Ventia Services Group Ltd |
- -% | 4.07 | 19.29 | 13.99 | 0.57 | 5.46 | 0.65 | 7.83 |
| SPZ Smart Parking Ltd |
- -% | 0.76 | 76.50 | 26.81 | 5.16 | 9.60 | 5.23 | 20.26 |
| AVD Avada Group Ltd |
- -% | 0.40 | - | - | 0.16 | 0.70 | 0.37 | 5.67 |
Atlas Arteria Limited develops and operates toll roads in France, Germany, and the United States. It holds 30.82% of interest in the APRR and 30.85% interest in the ADELAC located in France; 100% interest in the Warnow Tunnel located in Rostock, Germany; 66.67% interest in the Chicago Skyway situated in Chicago, United States; and 100% interest in the Dulles Greenway located in Virginia, United States. The company was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. Atlas Arteria Limited was incorporated in 2009 and is based in Melbourne, Australia.
180 Flinders Street, Melbourne, VIC, Australia, 3000
| Name | Title | Year Born |
|---|---|---|
| Mr. Graeme Francis Bevans | MD, CEO & Exec. Director | 1958 |
| Mr. Vincent Portal-Barrault | Chief Operating Officer | NA |
| Mr. David Collins | Chief Financial Officer | NA |
| Chloe Ranicar | Mang. of Investor Relations | NA |
| Tess Palmer | Director of Investor Relations | NA |
| Mr. Clayton John McCormack B.Com., BCom, L.L.B., LLB | Company Sec. & Gen. Counsel | NA |
| Navleen Prasad | Public Affairs Mang. | NA |
| Mr. Paul Lynch B.Com., L.L.B. | Joint Company Sec. | NA |
| Mr. Ryan Reynolds C.F.A. | Specialist of Forecasting and Analysis | NA |
| Mr. Graeme Francis Bevans | MD, CEO & Executive Director | 1958 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
US 
AU
UK
CA
NZ
Please wait processing your request...